NFKB1 and Alzheimer disease: In parallel, NF-κB and PPARG interactions have been reported to influence lipid metabolic and anti-inflammatory responses in other inflammatory disorders, suggesting a potential regulatory mechanism in AD, although direct evidence remains limited [27,28].